Peripherally restricted acute phase response to a viral mimic alters hippocampal gene expression

Lindsay T Michalovicz1, Gregory W Konat

  • 1Department of Neurobiology and Anatomy, West Virginia University School of Medicine, 1 Medical Center Dr., 4052 HSCN, P.O. Box 9128, Morgantown, WV, 26506-9128, USA.

Metabolic Brain Disease
|December 24, 2013
PubMed

Insights

Peripheral acute phase response (APR) increases brain seizure susceptibility for up to 72 hours. This protracted hypersusceptibility involves complex gene and microRNA changes in the hippocampus.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Peripheral acute phase response (APR) can affect brain function.
  • Previous work showed viral mimic injection (polyinosinic-polycytidylic acid, PIC) causes temporary brain hypersusceptibility to excitotoxicity.
  • Kainic acid (KA) is used to model excitotoxic seizures.

Purpose of the Study:

  • To investigate the duration of PIC-induced seizure hypersusceptibility.
  • To identify specific genes and microRNAs involved in the protracted hypersusceptibility.

Main Methods:

  • Mice were injected with PIC to induce APR.
  • Seizure susceptibility was measured using kainic acid (KA).
  • Hippocampal gene and microRNA expression were analyzed using RT-PCR at various time points (6h, 24h, 72h).

Main Results:

  • PIC-induced seizure hypersusceptibility persisted for up to 72 hours.
  • Rapid upregulation of 23 immune-related genes (cytokines, chemokines, receptors) occurred within 6 hours, with some persisting to 72 hours (Ccl19, Cxcl13, Ccr1, Ccr7).
  • Genes involved in neurotransmission showed dynamic changes, with Gabrr3 remaining upregulated at 72 hours. Ten microRNAs (miRs) exhibited oscillating expression patterns.

Conclusions:

  • Peripheral APR induces a prolonged state of brain seizure hypersusceptibility.
  • This phenomenon is associated with a sustained, complex polygenic and microRNA response in the hippocampus.
  • Specific chemokine, chemokine receptor, and neurotransmission-related genes, along with microRNAs, may play key roles in maintaining this hypersusceptible state.